Immunity against SARS-CoV-2 Omicron variant

Immunity against SARS-CoV-2 Omicron variant - Omicron variant immunity

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON55169

Enrollment

2000

Registered

2020-04-03

Start date

2020-04-19

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronavirus COVID

Interventions

None listed

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Adults > 18 years, with confirmed SARS-CoV-2 omicron infection.

Exclusion criteria

Exclusion criteria: geen

Design outcomes

Primary

Measure	Time frame
The key objective of the study is to characterize the immune response against SARS-CoV-2 omicron variant.	—

Secondary

Measure	Time frame
Secondary objectives: 1. Does the clinical course of disease correlate to viral loads and the immune response? 2. How is the CT value of the PCR correlated with the viability of the virus ? 3. How is the immune response correlated to viability of the virus?	—

Countries

Netherlands

Outcome results